ASCO 2026 | The association between elevated red cell distribution width-to-albumin ratio & incident cancer risk
In this video, Parham Habibzadeh, MD, University of Pittsburgh, Pittsburgh, PA, discusses the findings of a prospective cohort study examining the association between elevated red blood cell distribution width-to-albumin ratio (RAR) and incident cancer risk, highlighting that a high RAR can predict cancer development, particularly for hematological malignancies and some solid cancers. Dr Habibzadeh notes the accessibility of this prognostic biomarker, as it can be calculated using values present on a routinely performed standard blood panel. This interview took place during the 2026 American Society of Clinical Oncology (ASCO) Meeting in Chicago, IL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
